These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of drug reimportation on managed care pharmacy. Penna P Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216 [No Abstract] [Full Text] [Related]
5. Trajectories of Injectable Cancer Drug Costs After Launch in the United States. Gordon N; Stemmer SM; Greenberg D; Goldstein DA J Clin Oncol; 2018 Feb; 36(4):319-325. PubMed ID: 29016226 [TBL] [Abstract][Full Text] [Related]
6. US presidential candidates' proposals to reduce drug prices. Jaffe S Lancet; 2016 Aug; 388(10047):855-6. PubMed ID: 27597455 [No Abstract] [Full Text] [Related]
7. Rising drug prices drive US manufacturers' revenues, analysis finds. McCarthy M BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098 [No Abstract] [Full Text] [Related]
8. Pharmaceutical forecasting: throwing darts? Cha M; Rifai B; Sarraf P Nat Rev Drug Discov; 2013 Oct; 12(10):737-8. PubMed ID: 24080692 [No Abstract] [Full Text] [Related]
9. Notable deals in the pharmaceutical industry in the fourth quarter of 2016. D'Souza P Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386 [TBL] [Abstract][Full Text] [Related]
10. Recent Trends in Prescription Drug Launch Prices. Ybarra M; Weissman R JAMA; 2022 Oct; 328(13):1352. PubMed ID: 36194225 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: cost savings. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891 [No Abstract] [Full Text] [Related]
12. Maintaining drug supply to Greece in an uncertain future. Burki TK Lancet Oncol; 2015 Aug; 16(8):e382. PubMed ID: 26166437 [No Abstract] [Full Text] [Related]
13. The latest trends in the pharmaceutical market. Teitelbaum F Case Manager; 2000; 11(5):70-4. PubMed ID: 11935588 [No Abstract] [Full Text] [Related]
14. No money, no meds. Mabry M Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
15. Strategies for developing and commercializing nanobio drugs, diagnostics and devices. Bunger M Nanomedicine (Lond); 2007 Apr; 2(2):137-41. PubMed ID: 17716115 [No Abstract] [Full Text] [Related]
16. Pharma 2020--An Economist Conference Shaping the Future of the Pharmaceuticals Industry. Kibble A IDrugs; 2008 May; 11(5):331-3. PubMed ID: 18465672 [No Abstract] [Full Text] [Related]
17. States combat drug costs. Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442 [No Abstract] [Full Text] [Related]
18. The shape of European business in 2003. Wagner M Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520 [No Abstract] [Full Text] [Related]
19. Democracy unleashed--unpacking the tooth fairy in drug industry R&D. Ozdemir V; Williams-Jones B Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467 [No Abstract] [Full Text] [Related]
20. Market watch: Sales of biologics to show robust growth through to 2013. Goodman M Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035 [No Abstract] [Full Text] [Related] [Next] [New Search]